In Harrington v. Purdue Pharma L.P., will the Supreme Court rule that a bankruptcy court could approve OxyContin-maker Purdue Pharma's reorganization plan, which includes nonconsensual, nondebtor releases?

Started Oct 06, 2023 05:00PM UTC
Closing Jul 01, 2024 07:01AM UTC
Challenges
Tags

Purdue Pharma declared bankruptcy as it faced heavy liability for its role in the US opioid crisis, and agreed in a bankruptcy court to contribute billions of dollars in exchange for, among other things, a release from further civil liability for the Sackler family owners of the firm (AP, CNN, USA Today). A federal district court ruled that the bankruptcy court lacked the authority to approve a plan that included nonconsensual releases for third parties, which the Second Circuit reversed due to binding precedent (Oyez, SCOTUSblog, Second Circuit - In Re: Purdue Pharma (2023)). The Supreme Court is expected to hand down its decision in its 2023 term, but if it does not, the question will close as "No." If the Court decides this case without addressing this question's particular issue of law, the question will close as "No."

Confused? Check our FAQ or ask us for help. To learn more about Good Judgment and Superforecasting, click here.

To learn more about how you can become a Superforecaster, see hereFor other posts from our Insights blog, click here.

Possible Answer Crowd Forecast Change in last 24 hours Change in last week Change in last month
Yes 62.27% 0% 0% -4.18%
No 37.73% 0% 0% +4.18%

Sign up or sign in to forecast!

Sign Up Sign In
Files
Tip: Mention someone by typing @username